Related Experiment Video
Updated: Jun 27, 2026
09:27
Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins
Published on: January 17, 2014
7.7K
A chemical method for generating live-attenuated, replication-defective DNA viruses for vaccine development
Dabbu Kumar Jaijyan1, Kavitha Govindasamy2, Moses Lee3
1Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers - New Jersey Medical School, 225 Warren Street, Newark, NJ 07103, USA.
Cell Reports Methods
|September 26, 2022
Summary
This study introduces centanamycin (CM) as a novel chemical agent to create live-attenuated, replication-defective DNA virus vaccines. CM-attenuated vaccines demonstrated efficacy in generating immune responses and reducing viral load in preclinical models.
Area of Science:
- Virology
- Vaccinology
- Chemical Biology
Background:
- Live-attenuated virus vaccines are effective against DNA viral diseases.
- Developing replication-defective viruses is crucial for vaccine safety and efficacy.
- Chemical attenuation offers a novel approach to virus modification.
Purpose of the Study:
- To develop a method for producing live-attenuated, replication-defective DNA viruses using chemical attenuation.
- To evaluate the broad applicability of this method across different DNA viruses.
- To assess the immunogenicity and protective efficacy of a chemically attenuated vaccine in a preclinical model.
Main Methods:
- Utilized centanamycin (CM), a DNA-alkylating agent, to induce replication defects in viruses.
- Tested CM efficacy on human cytomegalovirus, mouse cytomegalovirus (MCMV), and herpes simplex virus-2 (HSV-2).
- Performed mass spectrometry to identify the site of CM alkylation on viral DNA.
- Immunized mice with CM-attenuated MCMV and challenged with wild-type MCMV.
Main Results:
- Successfully generated live-attenuated, replication-defective human cytomegalovirus, MCMV, and HSV-2.
- Confirmed CM alkylates viral DNA at the adenine-N3 position.
- CM-attenuated MCMV vaccination induced a robust immune response in mice.
- Vaccinated mice showed reduced viral load upon challenge with wild-type MCMV.
Conclusions:
- Centanamycin (CM) provides a versatile method for creating live-attenuated, replication-defective DNA virus vaccines.
- Chemically attenuated DNA viruses represent a promising new class of frontline vaccines.
- This approach offers a unifying strategy for developing vaccines against various DNA viruses.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...